Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    AGBA

    MCap

    USD93m

    Last close

    USD2.50

    ▲ 1.25 (100.00%)

    Pharnext

    MCap

    1m

    Last close

    EUR0.10

    ▲ 0.03 (42.86%)

    MGI – Media and Games Invest

    MCap

    EUR235m

    Last close

    EUR1.50

    ▲ 0.35 (30.21%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

QinetiQ Group — Update 18 April 2016

QinetiQ Group — Update 18 April 2016

QinetiQ Group

Analyst avatar placeholder

Written by

QinetiQ Group

Competitive evolution continues

Pre-results update

Aerospace & defence

18 April 2016

Price

224.00p

Market cap

£1,314m

Net cash (£m) as at 30 September 2015

181.5

Shares in issue

586.7m

Free float

95%

Code

QQ

Primary exchange

LSE

Secondary exchange

N/A

Share price performance

%

1m

3m

12m

Abs

(5.0)

(9.3)

13.5

Rel (local)

(7.8)

(16.3)

25.4

52-week high/low

274.4p

195.1p

Business description

QinetiQ provides technical support services to customers in the global aerospace, defence and security markets. The group operates through two divisions: EMEA Services (82% FY15 sales) and Global Products (18% FY15 sales).

Next event

Full year results

26 May 2016

Analyst

Roger Johnston

+44 (0)20 3077 5722

QinetiQ Group is a research client of Edison Investment Research Limited

QinetiQ’s pre-close statement highlighted that the company is on course to achieve full year expectations. In addition to contract wins, the statement also highlighted the key outcomes from the Single Source Regulations Office (SSRO) baseline profit rate review. While this provides a level of certainty in the short term, further development of the rate for outer years is yet to be finalised consistent with management’s guidance for a moderation of margins in EMEA Services, as modelled in our forecasts. With results due on 26 May, we expect the group to further articulate its strategic evolution to enhance customer focus and competitiveness.

Year end

Revenue (£m)

PBT*
(£m)

EPS*
(p)

DPS
(p)

P/E
(x)

Yield
(%)

03/14

782.6

101.2

13.8

4.6

16.2

2.1

03/15

763.8

107.8

15.2

5.4

14.7

2.4

03/16e

776.6

105.5

15.4

5.7

14.5

2.5

03/17e

784.0

103.9

15.5

6.0

14.4

2.7

Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.

Pre-close highlights on track to deliver

QinetiQ delivered a strong set of interims in November even during the uncertainty surrounding the election and SDSR, while the £50m buyback provided further evidence of the group’s clear approach to capital allocation with excess cash returned to shareholders. The pre-close statement reaffirmed that the group is on track to deliver to expectations with contract announcements in EMEA Services and trading as expected in Global Products.

Unpicking the SSRO pricing outcome

The SSRO’s pricing review was announced by the UK Secretary of State for Defence on 14 March which will see the baseline rate set at 8.95% vs the current 10.6%. This will apply to new and renewed contracts between 1 April 2016 and 31 March 2017 after which a further evolution of the methodology will be used to develop the profit rate in future years. It is important to note that the rate is a starting point: average achieved industry rates were 12.48% in FY15 and we estimate that QinetiQ has c £450m of single source contracts. Many of these are structured under long-term agreements which roll on average every three to four years. As a result, we feel it will take time for the effect of any changes to be felt.

Valuation: Strong cash generation supports view

With full year results due in May that are likely to present an evolution of the strategy in line with the key priorities outlined by Steve Wadey at the interims, our positive investment case remains rooted in the continued strong cash-generative nature of the group. This provides QinetiQ with options for value creation and a clear capital allocation policy designed to kick-start organic growth while returning excess capital when appropriate. Our support service-based fair value is 237p/share.

Pre-close highlights continued progress

QinetiQ’s pre-close statement at the end of March highlighted that the group continues to deliver a resilient performance despite ongoing pressure in Global Products and the uncertainty caused by the SSRO pricing methodology debate. The group highlighted that trading was as anticipated and several new contracts had been won since the interim results in November across both divisions:

■

EMEA Services: Continued its performance as outlined in the Q3 statement in February with performance in line with expectations and some de-scoping and delays continuing. The company announced a five-year follow on contract in Australia, with rolling extensions up to 15 years, to provide aircraft structural integrity services to the Australian Defence Force. This follows on from the UK Cyber and Training business contracts with Motorola Solutions to provide monitoring, assessment and assurance services in support of the delivery of the UK Emergency Services Network and the £153m five-year renewal from the UK Ministry of Defence (MOD) for aircraft engineering support announced alongside the interim results.

■

Global Products: Trading in Global Products also continued as expected with several smaller wins announced through the half. This included further small robot and survivability orders for both US and overseas customers as well as a strategically important Optasense order to protect c 2000km of pipeline. Once the contract is completed, it will be the world’s largest distributed fibre sensing project with half of the $30m project contracted to Optasense. We believe that these contracts, coupled with the small backlog increase at H1, are a signal that the significant revenue decrease witnessed in the division is coming to an end.

Government reviews continue to influence strategy decisions

Circa 90% of group revenues are generated in the UK, while 66% of group revenues were derived from the MoD in H1, therefore the group is influenced by the outcomes of government policy reviews. With the SDSR released at the end of November 2015 and the outcome of the Single Source Responsibility Office (SSRO) pricing review released in March, two areas of potential short-term uncertainty for QinetiQ’s EMEA business have passed.

SDSR broadly neutral

The UK’s SDSR was broadly neutral for the group in our view with a number of specific commitments that could be seen as supportive and some others that were less so. Overall, we view the SDSR as broadly neutral for QinetiQ, largely due to its position across a broad range of programmes, and partly due to the fact that although priorities have been articulated, the detailed workings of the effects are likely to take some time to work through.

SSRO pricing review clarity, for now

Potentially with more of a direct effect, the SSRO’s pricing review was announced by the Secretary of State for Defence on 14 March 2016. This concluded that there will be a single baseline profit rate for single source defence contracts of 8.95% (vs 10.6% this year in 2015/16). This rate applies to new or renewed qualifying contracts signed from 1 April 2016 to March 2017. The Secretary for State also announced that the SSRO will further develop the methodology used to calculate the baseline profit rate over the next year for future years. We believe there are several important points that this raises:

■

Baseline clarity for FY17. With the uncertainty surrounding methodology and the potential impact having dragged on through FY16, the announcement provided clarity for the baseline rate in FY17 around which QinetiQ can plan. The baseline rate is simply the starting point for negotiations which are then adjusted for influences such as risk, etc. As highlighted in the SSRO’s Q&A regarding the baseline methodology approach, the average profit rate agreed during 2015/16 was actually 12.48% vs the baseline of 10.6%. We note that it is also possible to achieve a higher rate than agreed at contract signing by reducing costs and improving efficiency, a key strength of QinetiQ.

■

Applies to new or renewed qualifying contracts. As stipulated by the SSRO, the new baseline profit rate is applied to new or renewed qualifying contracts. Qualifying Defence Contracts (QDC) are those for goods or services for defence purposes, those that are not the result of a competitive process and that are for more than £5m, although the principles are likely to apply to all single source defence contracts. Within QinetiQ’s business there are c £450m of single source contracts, several of which are long-term partnership agreements, the largest of which, the c £200m pa LTPA, is renewed every five years with the last five-year period agreed in February 2013. Overall, we estimate that on average, the single source element of the group’s revenue will be renewed every three to four years, which gives an indication of the rate at which new baseline profit changes could take effect. In the short term, QinetiQ generally starts the beginning of the year with between 70-80% of that year’s revenues already in the order book; hence the effect would lag the contract rate changes.

■

Further methodology to be agreed. The SSRO has also been tasked with developing a proposal for multiple baseline rates for adoption in 2017/18 depending on the activity type being undertaken. With the baseline profit methodology based on a comparison with a group of international defence companies, this may prove difficult in circumstances whereby unique capabilities exist. There will be further consultation so further uncertainty is likely into 2017 and beyond regarding the actual outcome.

Financials: Continued resilience despite margin pressure

We have updated our financials marginally, reducing our 2016 forecast and adding a 2017 forecast that demonstrates the ongoing strength of the group. Exhibit 1 below highlights our divisional and group forecasts for both FY16 and FY17. They reflect a stable performance with EPS benefitting from the ongoing £50m share buyback initiated at the time of the interims:

Exhibit 1: Edison's divisional and group forecasts of QinetiQ

Y/end March

FY14

FY15

Growth (%)

FY16e

Growth (%)

FY17e

Growth (%)

EMEA Services

Sales

607

625.6

3.1

635.0

1.5

638.8

0.6

Operating profit

86.7

93.0

7.3

87.6

-5.8

86.2

-1.6

Margin (%)

14.3

14.9

+60bps

13.8

-110bps

13.5

-30bps

Global Products

Sales

175.6

138.2

-21.3

141.6

2.5

145.2

2.5

Operating profit

27

18.3

-32.2

18.4

0.6

18.2

-1.4

Margin (%)

15.4

13.2

-220bps

13.0

-20bps

12.5

-50bps

Group

Sales

782.6

763.8

-2.4

776.6

1.7

784.0

1.0

Operating profit

113.7

111.3

-2.1

106.0

-4.7

104.4

-1.6

Margin

14.5

14.6

+10bps

13.7

-90bps

13.3

-40bps

Net Interest

-12.5

-3.5

-72.0

-0.5

-85.7

-0.5

0.0

Underlying PBT

101.2

107.8

6.5

105.5

-2.1

103.9

-1.6

Adjusted tax

-11.4

-11.8

3.5

-14.8

25.4

-15.1

2.0

Underlying tax rate (%)

11.3

10.9

-2.8

14.0

28.1

14.5

3.6

Underlying profit after tax

89.8

96.0

6.9

90.7

-5.5

88.8

-2.1

Average shares in issue (m)

651.7

630.9

-3.2

588.5

-6.7

573.4

-2.6

Underlying EPS (p)

13.8

15.2

10.4

15.4

1.3

15.5

0.4

Source: Edison Investment Research

Priorities articulated, strategy evolution likely in May

At the interim results, CEO Steve Wadey laid out his key priorities for the group and we believe that results in May are likely to provide more of an evolutionary rather than revolutionary update on the strategy. Several key areas of priority were highlighted for further improvement to enhance customer focus and competitiveness:

■

Business winning. With order performance remaining muted, business winning is key to drive future growth. Improved business development capabilities were highlighted both in the UK and internationally, an area we feel that QinetiQ is only just beginning to tap in earnest. In particular, a clear understanding of customer requirements in a changing and demanding defence environment is required and programmes have been developed to enhance this. In addition, strategic campaigns will be corporately led to ensure that the best teams from across the business are deployed.

■

Core competencies supporting growth. With a wide range of competencies across the group, many of which are unique, there are several opportunities to link not just to traditional defence customer requirements but also into adjacent industries. Key areas such as Space and Security which are currently nascent businesses are expected to be developed further.

■

Investing in the future. To support organic growth, QinetiQ launched an internal R&D programme to control the investment in organic capabilities to develop the most appropriate solutions and services that are both innovative and competitive. This programme was also put in place to ensure that such development is aligned with customer needs and that investment matches the corporate capital allocation priorities. As such, targeted M&A could be undertaken.

■

Operational excellence. While focused on optimising profit in the short term, longer-term productivity and efficiency will enable the group to better compete in terms of competitiveness. To enable this, an integrated business planning process is being implemented as part of the management process which will match effective delivery and efficiency with longer-term strategic needs. Supporting this, a leadership community of the top 100 leaders was also created to meet monthly and ensure targets are being met and focus is maintained.

Allied to these more operational measures, there was also a very clear capital allocation policy which continues to guide the group in its decision making. This clearly prioritised:

■

Investment in organic growth

■

Bolt-on acquisitions where there is a technological and strategic fit

■

Maintaining a strong balance sheet

■

Maintaining a progressive dividend

■

Returning any excess capital to shareholders as shown by the £50m share buyback announced at interims

We expect that the FY15 results due on 26 May will likely highlight how QinetiQ has progressed in its strategic evolution and demonstrate the initial benefits from some of the programmes initiated during the CEO’s first year. While we anticipate that market conditions remain challenging, we also feel that the combination of operational focus, strong balance sheet and alignment of capabilities with emerging defence and security threats position QinetiQ to provide a solid foundation for future organic growth.

Valuation supported by continued cash generation

With significant balance sheet flexibility and a clear capital allocation priority, we continue to view QinetiQ as supported by its strong underlying cash generation capability. While margin pressures remain and management has flagged the potential for some working capital reversal, we forecast that QinetiQ will generate some £135m of free cash flow over the next two years. Exhibit 2 below highlights the peer group with which we compare QinetiQ.

Exhibit 2: Relative peer valuation and financial metrics

Year
end

Share price

P/E FY16e

P/E FY17e

EV/EBITDA FY16e

EV/EBITDA FY17e

Div yield FY16e

Div yield FY17e

FCF yield FY16e

FCF yield FY17e

ROCE FY16e

ROCE FY17e

Serco

Dec

97.1

46.2

24.9

11.7

11.7

0.0%

0.0%

7.0%

6.8%

9.0%

6.3%

Babcock

Mar

987.0

13.3

12.2

10.1

9.4

2.6%

2.9%

-1.9%

0.7%

15.7%

0.0%

WS Atkins

Mar

1385.0

13.8

12.0

7.7

6.8

2.8%

3.0%

4.5%

3.2%

35.6%

0.0%

Capita

Dec

1065.0

13.5

12.8

11.1

10.6

3.2%

3.4%

5.7%

6.5%

6.9%

57.7%

G4S

Dec

196.4

12.8

11.8

8.2

7.9

4.8%

5.0%

6.4%

6.2%

1.0%

23.6%

Cubic Corp

Sep

40.8

21.7

13.8

10.8

8.7

0.6%

0.9%

-3.9%

-4.4%

3.0%

10.3%

Avg (support services)

15.0

12.5

9.6

8.7

2.8%

3.0%

2.2%

2.4%

12.4%

Ultra Electronics

Dec

1780

13.0

12.4

10.5

10.1

2.7%

2.9%

5.5%

6.1%

7.9%

27.4%

Chemring

Oct

140.25

12.3

10.6

6.7

6.2

2.3%

2.6%

2.7%

5.0%

7.8%

0.0%

Kongsberg Group

Dec

137.5

16.6

14.5

8.4

7.7

3.5%

3.8%

6.1%

7.2%

12.1%

15.4%

Cobham

Dec

205.2

10.9

10.2

8.3

8.3

5.7%

5.9%

7.6%

8.9%

-3.7%

17.1%

Avg (defence subcontractors)

13.2

11.9

8.5

8.1

3.6%

3.8%

5.5%

6.8%

6.0%

15.0%

QinetiQ

Mar

224.3

14.5

14.5

8.6

8.5

2.5%

2.7%

6.0%

6.0%

28.8%

28.3%

Average (combined)

14.2

12.3

9.1

8.4

3.1%

3.4%

3.6%

4.4%

9.6%

16.8%

Source: Bloomberg. Note: Prices as at 14 April 2016.

We believe that using the support service peer group multiples continues to provide an appropriate measure due to the visibility, cash generative nature and relative strength of the core group. Exhibit 3 below highlights the range of fair value approaches utilising our FY16 forecasts.

Exhibit 3: Fair value ranges based on relative peer ratings (FY16 basis)

(p)

Support service

Defence contractor

Combined

P/E

231

204

219

EV/EBITDA

242

222

233

Average

237

213

226

Source: Edison Investment Research

Our support service methodology yields a fair value of 237p/share. With short-term clarity achieved regarding the SSRO pricing consistent with guidance from management, we feel that the FY15 results in May should provide a further catalyst as CEO Steve Wadey expands on his initial priorities.

Exhibit 4: Financial summary

£m

2013

2014

2015

2016e

2017e

Year-end 31 March

IFRS

IFRS

IFRS

IFRS

IFRS

PROFIT & LOSS

Revenue

 

 

1,327.8

782.6

763.8

776.6

784.0

Cost of Sales

N/A

N/A

N/A

N/A

N/A

Gross Profit

N/A

N/A

N/A

N/A

N/A

EBITDA

 

 

200.7

144.9

135.6

130.5

129.1

Operating Profit (before amort. and except.)

 

 

168.7

113.7

111.3

106.0

104.4

Intangible Amortisation

(14.0)

(3.4)

(2.8)

(2.4)

(2.4)

Exceptionals

(275.1)

28.4

1.0

0.0

0.0

Other

0.0

0.0

0.0

0.0

0.0

Operating Profit

(120.4)

138.7

109.5

103.6

102.0

Net Interest

(16.6)

(12.5)

(3.5)

(0.5)

(0.5)

Profit Before Tax (norm)

 

 

152.1

101.2

107.8

105.5

103.9

Profit Before Tax (FRS 3)

 

 

(137.0)

126.2

106.0

103.1

101.5

Tax

3.8

(16.0)

12.0

(14.8)

(15.1)

Profit After Tax (norm)

122.9

89.8

96.0

90.7

88.8

Profit After Tax (FRS 3)

(133.2)

110.2

105.3

88.3

86.4

Average Number of Shares Outstanding (m)

650.5

651.7

630.9

588.5

573.4

EPS - normalised (p)

 

 

18.9

13.8

15.2

15.4

15.5

EPS - (IFRS) (p)

 

 

(20.5)

16.9

16.7

15.0

15.1

Dividend per share (p)

3.8

4.6

5.4

5.7

6.0

Gross Margin (%)

N/A

N/A

N/A

N/A

N/A

EBITDA Margin (%)

15.1

18.5

17.8

16.8

16.5

Operating Margin (before GW and except.) (%)

12.7

14.5

14.6

13.7

13.3

BALANCE SHEET

Fixed Assets

 

 

626.7

439.4

366.3

372.7

378.3

Intangible Assets

348.2

185.5

122.5

120.9

118.5

Tangible Assets

241.4

233.8

229.6

237.6

245.6

Investments

37.1

20.1

14.2

14.2

14.2

Current Assets

 

 

554.1

597.7

376.6

382.6

388.6

Stocks

25.5

19.8

18.5

21.5

24.5

Debtors

285.6

252.6

159.2

162.2

165.2

Cash

240.4

322.2

184.3

184.3

184.3

Other

2.6

3.1

14.6

14.6

14.6

Current Liabilities

 

 

(486.6)

(437.2)

(372.5)

(379.3)

(381.4)

Creditors

(484.6)

(435.0)

(370.6)

(377.4)

(379.5)

Short-term borrowings

(2.0)

(2.2)

(1.9)

(1.9)

(1.9)

Long-Term Liabilities

 

 

(255.7)

(221.8)

(72.3)

(61.5)

(72.2)

Long-term borrowings

(171.3)

(154.1)

(0.1)

7.7

(5.0)

Other long-term liabilities

(84.4)

(67.7)

(72.2)

(69.2)

(67.2)

Net Assets

 

 

439

378

298

315

313

CASH FLOW

Operating Cash Flow

 

 

257.5

141.4

138.9

105.2

104.8

Net Interest

(35.0)

(10.5)

(35.4)

0.0

0.0

Tax

(1.6)

2.9

9.0

(5.0)

(10.0)

Capex

(17.9)

(18.2)

(24.8)

(30.0)

(30.0)

Acquisitions/disposals

3.2

(2.6)

71.7

27.4

0.0

Financing

(0.4)

(0.5)

(106.8)

(55.3)

(40.0)

Dividends

(20.1)

(26.8)

(31.7)

(34.0)

(37.0)

Net Cash Flow

185.7

85.7

20.9

8.3

(12.2)

Opening net debt/(cash)

 

 

122.2

(74.0)

(170.5)

(195.5)

(203.8)

HP finance leases initiated

0.0

0.0

0.0

0.0

0.0

Other

10.5

10.8

4.1

0.0

0.0

Closing net debt/(cash)

 

 

(74.0)

(170.5)

(195.5)

(203.8)

(191.6)

Source: Company accounts, Edison Investment Research

Edison, the investment intelligence firm, is the future of investor interaction with corporates. Our team of over 100 analysts and investment professionals work with leading companies, fund managers and investment banks worldwide to support their capital markets activity. We provide services to more than 400 retained corporate and investor clients from our offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2016 Edison Investment Research Limited. All rights reserved. This report has been commissioned by QinetiQ Group and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2016. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 9258 1161

Level 25, Aurora Place

88 Phillip St, Sydney

NSW 2000, Australia

Wellington +64 (0)48 948 555

Level 15, 171 Featherston St

Wellington 6011

New Zealand

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 9258 1161

Level 25, Aurora Place

88 Phillip St, Sydney

NSW 2000, Australia

Wellington +64 (0)48 948 555

Level 15, 171 Featherston St

Wellington 6011

New Zealand

RXi Pharmaceuticals — Update 18 April 2016

RXi Pharmaceuticals

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free